Delivery Order SPE2DB20D3104-SPE2DB23FV6J5
Award Date
4/26/23
Potential Completion Date
4/27/23
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,124.76 firm-fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET medication. The contract has an ultimate completion date of April 1, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,348.81 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,044.08 firm fixed-price delivery order contract is for the provision of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,475.62 Firm Fixed Price Delivery Order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The award has a completion date of February 21, 2023 and was made on February 17, 2023. This contract is a child order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,319.70 firm-fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET medication, with a completion date of November 25, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,949.63 Firm Fixed Price Delivery Order provides XELJANZ XR 11 MG Tablets for a period ending on March 18, 2025. The award is not associated with a set-aside contract and is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XELJANZ XR 11 MG TABLET prescription medication. The firm-fixed-price delivery order, valued at $39,154.40, has a completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,925.35 Firm Fixed Price Delivery Order contract is for the supply of XELJANZ XR 11 MG TABLET 30S, a prescription medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,869.95 firm fixed-price delivery order covers the supply of XELJANZ XR 11 MG TABLET medication, without any set-aside designation. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,341.52 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a medication used to treat various conditions. The contract has an ultimate completion date of May 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...